MCH ADVISORY RESEARCH
Health Care

Health Care Equipment

16 companies under coverage.

Coverage

Health Care Equipment


Equity Research

ResMed Inc (RMD)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $357, +83% vs spot. It needs the multiple to hold or expand.

RMDEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · +3%
Equity Research

Boston Scientific Corp (BSX)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $77, +81% vs spot. It needs the multiple to hold or expand.

BSXEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · +3%
Equity Research

Medtronic PLC (MDT)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $148, +89% vs spot. It needs the multiple to hold or expand.

MDTEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · +1%
Equity Research

STERIS plc (STE)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $375, +78% vs spot. It needs the multiple to hold or expand.

STEEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -6%
Equity Research

Baxter International Inc (BAX)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $37, +73% vs spot. It needs Gross Margin to surprise to the upside.

BAXEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -6%
Equity Research

GE HealthCare Technologies Inc. (GEHC)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $113, +76% vs spot. It needs Gross Margin to surprise to the upside.

GEHCEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -7%
Equity Research

Abbott Laboratories (ABT)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $165, +82% vs spot. It needs the multiple to hold or expand.

ABTEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -7%
Equity Research

Zimmer Biomet Holdings Inc (ZBH)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $163, +89% vs spot. It needs the multiple to hold or expand.

ZBHEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -9%
Equity Research

IDEXX Laboratories Inc (IDXX)

The bull case — 'Bull — Premium Re-Rate' (8% weight) — targets $992, +89% vs spot. It needs the multiple to hold or expand.

IDXXEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -9%
Equity Research

Edwards Lifesciences Corp (EW)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $160, +77% vs spot. It needs the multiple to hold or expand.

EWEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -9%
Equity Research

DexCom Inc (DXCM)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $120, +79% vs spot. It needs the multiple to hold or expand.

DXCMEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -9%
Equity Research

Insulet Corporation (PODD)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $272, +79% vs spot. It needs the multiple to hold or expand.

PODDEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -10%
Equity Research

Intuitive Surgical Inc (ISRG)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $714, +80% vs spot. It needs the multiple to hold or expand.

ISRGEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -10%
Equity Research

Stryker Corporation (SYK)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $558, +77% vs spot. It needs the multiple to hold or expand.

SYKEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -11%
Equity Research

Revvity Inc. (RVTY)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $201, +80% vs spot. It needs the multiple to hold or expand.

RVTYEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -11%
Equity Research

Becton Dickinson and Company (BDX)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $263, +74% vs spot. It needs the multiple to hold or expand.

BDXEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -17%
MCH ADVISORY SERVICES · All research · Not investment advicemchadvisoryservices.com ↗ · Research Standard v3.2 · US-listed comparatives · UK English